Meeting
2023 ASCO Genitourinary Cancers Symposium
Validation of AGR2 and KRT19 as specific proteins being significantly and differentially expressed in teratoma compared to necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND).
Authors
Tim Nestler
Department of Urology, University Hospital of Cologne, Cologne, Germany
Tim Nestler , Lara Kremer , Melanie von Brandenstein , Maike Wittersheim , Svenja Wagener-Ryczek , Pia Paffenholz , Stefan Mueller , Alexander Quaas , Martin Hellmich , Margarete Odenthal , David Pfister , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 412)
DOI
10.1200/JCO.2023.41.6_suppl.412
Abstract #
412
Poster Bd #
L14
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND).
First Author: Tim Nestler
Poster
2022 ASCO Annual Meeting
Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT).
First Author: Jennifer King
Poster
2024 ASCO Annual Meeting
Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
First Author: Ahmed Bilal Khalid
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Reliability of computed tomography to determine the eligibility of conversion surgery for gastric cancer with para-aortic lymph node metastasis.
First Author: Takeyuki Wada